Stacey C. Sigmon, Ph.D. - Publications

Affiliations: 
University of Vermont, Burlington, VT, United States 

95 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Streck JM, Sigmon SC, Priest J, Bergeria CL, Davis DR, Hughes JR, Villanti AC, Tidey JW, Heil SH, Gaalema DE, Stitzer ML, Higgins ST. Investigating tobacco withdrawal in response to reduced nicotine cigarettes among smokers with opioid use disorder and other vulnerabilities. Experimental and Clinical Psychopharmacology. PMID 32027158 DOI: 10.1037/pha0000350  0.96
2020 Rey CN, Badger GJ, Melbostad HS, Wachtel D, Sigmon SC, MacAfee LK, Dougherty AK, Heil SH. Perceptions of Long-Acting Reversible Contraception among Women Receiving Medication for Opioid Use Disorder in Vermont. Contraception. PMID 32014521 DOI: 10.1016/j.contraception.2020.01.010  0.84
2020 Peck KR, Ochalek TA, Badger GJ, Sigmon SC. Effects of Interim Buprenorphine Treatment for opioid use disorder among emerging adults. Drug and Alcohol Dependence. 208: 107879. PMID 31991327 DOI: 10.1016/j.drugalcdep.2020.107879  0.84
2019 Davis DR, Miller ME, Streck JM, Bergeria CL, Sigmon SC, Tidey JW, Heil SH, Gaalema DE, Villanti AC, Stitzer ML, Priest JS, Bunn JY, Skelly JM, Diaz V, Arger CA, et al. Response to Reduced Nicotine Content in Vulnerable Populations: Effect of Menthol Status. Tobacco Regulatory Science. 5: 135-142. PMID 31890749 DOI: 10.18001/TRS.5.2.5  0.96
2019 Davis DR, Parker MA, Villanti AC, Streck JM, Priest JS, Tidey JW, Gaalema DE, Sigmon SC, Heil SH, Higgins ST. Examining Age as a Potential Moderator of Response to Reduced Nicotine Content Cigarettes in Vulnerable Populations. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 21: S49-S55. PMID 31867655 DOI: 10.1093/ntr/ntz134  0.96
2019 Gaalema DE, Tidey JW, Davis DR, Sigmon SC, Heil SH, Stitzer ML, Desarno MJ, Diaz V, Hughes JR, Higgins ST. Potential Moderating Effects of Psychiatric Diagnosis and Symptom Severity on Subjective and Behavioral Responses to Reduced Nicotine Content Cigarettes. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 21: S29-S37. PMID 31867653 DOI: 10.1093/ntr/ntz139  0.96
2019 Gaalema DE, Dube S, Potter A, Elliott RJ, Mahoney K, Sigmon SC, Higgins ST, Ades PA. The effect of executive function on adherence with a cardiac secondary prevention program and its interaction with an incentive-based intervention. Preventive Medicine. 105865. PMID 31662210 DOI: 10.1016/j.ypmed.2019.105865  0.96
2019 Parker MA, Sigmon SC, Villanti AC. Higher smoking prevalence among United States adults with co-occurring affective and drug use diagnoses. Addictive Behaviors. 99: 106112. PMID 31476691 DOI: 10.1016/j.addbeh.2019.106112  0.6
2019 Davis DR, DeSarno MJ, Bergeria CL, Streck JM, Tidey JW, Sigmon SC, Heil SH, Gaalema DE, Stitzer ML, Higgins ST. Examining effects of unit price on preference for reduced nicotine content cigarettes and smoking rate. Preventive Medicine. 105823. PMID 31470023 DOI: 10.1016/j.ypmed.2019.105823  0.96
2019 Streck JM, Davis DR, Pang RD, Sigmon SC, Bunn JY, Bergeria CL, Tidey JW, Heil SH, Gaalema DE, Hughes JR, Stitzer ML, Reed E, Higgins ST. Potential Moderating Effects of Sex/Gender on the Acute Relative Reinforcing and Subjective Effects of Reduced Nicotine Content Cigarettes in Vulnerable Populations. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 31225625 DOI: 10.1093/ntr/ntz098  0.96
2019 Peck KR, Parker MA, Sigmon SC. Reasons for non-medical use of prescription opioids among young adults: Role of educational status. Preventive Medicine. PMID 30951735 DOI: 10.1016/j.ypmed.2019.03.047  0.6
2019 Bergeria CL, Heil SH, Davis DR, Streck JM, Sigmon SC, Bunn JY, Tidey JW, Arger CA, Reed DD, Gallagher T, Hughes JR, Gaalema DE, Stitzer ML, Higgins ST. Evaluating the utility of the modified cigarette evaluation questionnaire and cigarette purchase task for predicting acute relative reinforcing efficacy of cigarettes varying in nicotine content. Drug and Alcohol Dependence. 197: 56-64. PMID 30776572 DOI: 10.1016/j.drugalcdep.2019.01.004  0.96
2019 Ochalek TA, Parker MA, Higgins ST, Sigmon SC. Fentanyl exposure among patients seeking opioid treatment. Journal of Substance Abuse Treatment. 96: 23-25. PMID 30466544 DOI: 10.1016/j.jsat.2018.10.007  0.96
2018 Parker MA, Streck JM, Bergeria CL, Bunn JY, Gaalema DE, Davis DR, Barrows AJ, Sigmon SC, Tidey JW, Heil SH, Higgins ST. Reduced Nicotine Content Cigarettes and Cannabis Use in Vulnerable Populations. Tobacco Regulatory Science. 4: 84-91. PMID 30417034 DOI: 10.18001/TRS.4.5.8  0.96
2018 Streck JM, Bergeria CL, Parker MA, Davis DR, DeSarno M, Sigmon SC, Hughes JR, Gaalema DE, Heil SH, Tidey JW, Stitzer ML, Rothman M, Higgins ST. Response to reduced nicotine content cigarettes among smokers with chronic health conditions. Preventive Medicine Reports. 12: 321-329. PMID 30416951 DOI: 10.1016/j.pmedr.2018.10.001  0.96
2018 Parker MA, Ochalek TA, Rose GL, Badger GJ, Sigmon SC. Feasibility of an interactive voice response system for daily monitoring of illicit opioid use during buprenorphine treatment. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. PMID 30359047 DOI: 10.1037/adb0000413  0.84
2018 Ochalek TA, Heil SH, Higgins ST, Badger GJ, Sigmon SC. A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study. Drug and Alcohol Dependence. 190: 224-228. PMID 30056321 DOI: 10.1016/j.drugalcdep.2018.05.032  0.96
2018 Streck JM, Ochalek TA, Miller ME, Meyer AC, Badger G, Teneback C, Dixon A, Higgins ST, Sigmon SC. Promoting smoking abstinence among patients with chronic obstructive pulmonary disease: Initial feasibility. Preventive Medicine Reports. 11: 176-179. PMID 29992083 DOI: 10.1016/j.pmedr.2018.06.016  0.96
2018 Streck JM, Ochalek TA, Badger GJ, Sigmon SC. Interim buprenorphine treatment during delays to comprehensive treatment: Changes in psychiatric symptoms. Experimental and Clinical Psychopharmacology. PMID 29939049 DOI: 10.1037/pha0000199  0.84
2018 Villanti AC, Gaalema DE, Tidey JW, Kurti AN, Sigmon SC, Higgins ST. Co-occurring vulnerabilities and menthol use in U.S. young adult cigarette smokers: Findings from Wave 1 of the PATH Study, 2013-2014. Preventive Medicine. PMID 29890187 DOI: 10.1016/j.ypmed.2018.06.001  0.96
2018 Higgins ST, Bergeria CL, Davis DR, Streck JM, Villanti AC, Hughes JR, Sigmon SC, Tidey JW, Heil SH, Gaalema DE, Stitzer ML, Priest JS, Skelly JM, Reed DD, Bunn JY, et al. Response to reduced nicotine content cigarettes among smokers differing in tobacco dependence severity. Preventive Medicine. PMID 29626557 DOI: 10.1016/j.ypmed.2018.04.010  0.96
2018 Parker MA, Streck JM, Sigmon SC. Associations between opioid and nicotine dependence in nationally representative samples of United States adult daily smokers. Drug and Alcohol Dependence. 186: 167-170. PMID 29579724 DOI: 10.1016/j.drugalcdep.2018.01.024  0.6
2018 Streck JM, Heil SH, Higgins ST, Bunn JY, Sigmon SC. Tobacco Withdrawal Among Opioid-Dependent Smokers. Experimental and Clinical Psychopharmacology. PMID 29389213 DOI: 10.1037/pha0000185  0.96
2017 Arger CA, Heil SH, Sigmon SC, Tidey JW, Stitzer ML, Gaalema DE, Durand HJ, Bunn JY, Ruggieri EK, Higgins ST. Preliminary validity of the modified Cigarette Evaluation Questionnaire in predicting the reinforcing effects of cigarettes that vary in nicotine content. Experimental and Clinical Psychopharmacology. 25: 473-478. PMID 29251976 DOI: 10.1037/pha0000145  0.96
2017 Arger CA, Heil SH, Sigmon SC, Tidey JW, Stitzer ML, Gaalema DE, Durand HJ, Bunn JY, Ruggieri EK, Higgins ST. Preliminary validity of the modified Cigarette Evaluation Questionnaire in predicting the reinforcing effects of cigarettes that vary in nicotine content. Experimental and Clinical Psychopharmacology. 25: 473-478. PMID 29251976 DOI: 10.1037/pha0000145  0.96
2017 Higgins ST, Heil SH, Sigmon SC, Tidey JW, Gaalema DE, Hughes JR, Stitzer ML, Durand H, Bunn JY, Priest JS, Arger CA, Miller ME, Bergeria CL, Davis DR, Streck JM, et al. Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction. Jama Psychiatry. PMID 28832876 DOI: 10.1001/jamapsychiatry.2017.2355  0.96
2017 Bergeria CL, Heil SH, Bunn JY, Sigmon SC, Higgins ST. Comparing Smoking Topography and Subjective Measures of Usual Brand Cigarettes Between Pregnant and Non-Pregnant Smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 28658941 DOI: 10.1093/ntr/ntx148  0.96
2017 Hughes JR, Callas PW, Priest JS, Etter JF, Budney AJ, Sigmon SC. Development of a Self-Report Measure of Reward Sensitivity:A Test in Current and Former Smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 19: 723-728. PMID 28486712 DOI: 10.1093/ntr/ntw272  0.6
2017 Hughes JR, Budney AJ, Muellers SR, Lee DC, Callas PW, Sigmon SC, Fingar JR, Priest J. Does Tobacco Abstinence Decrease Reward Sensitivity? A Human Laboratory Test. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 19: 677-685. PMID 28486707 DOI: 10.1093/ntr/ntw204  0.6
2017 Brooklyn JR, Sigmon SC. Vermont Hub-and-Spoke Model of Care For Opioid Use Disorder: Development, Implementation, and Impact. Journal of Addiction Medicine. PMID 28379862 DOI: 10.1097/ADM.0000000000000310  0.56
2017 Sigmon SC, Schwartz RP, Higgins ST. Buprenorphine for Persons on Waiting Lists for Treatment for Opioid Dependence. The New England Journal of Medicine. 376: 1000-1001. PMID 28273017 DOI: 10.1056/NEJMc1700539  0.96
2016 Sigmon SC, Ochalek TA, Meyer AC, Hruska B, Heil SH, Badger GJ, Rose G, Brooklyn JR, Schwartz RP, Moore BA, Higgins ST. Interim Buprenorphine vs. Waiting List for Opioid Dependence. The New England Journal of Medicine. 375: 2504-2505. PMID 28002704 DOI: 10.1056/NEJMc1610047  0.96
2016 Higgins ST, Heil SH, Sigmon SC, Tidey JW, Gaalema DE, Stitzer ML, Durand H, Bunn JY, Priest JS, Arger CA, Miller ME, Bergeria CL, Davis DR, Streck JM, Zvorsky I, et al. Response to varying the nicotine content of cigarettes in vulnerable populations: an initial experimental examination of acute effects. Psychopharmacology. PMID 27714427 DOI: 10.1007/s00213-016-4438-z  0.32
2016 Dunn KE, Barrett FS, Yepez-Laubach C, Meyer AC, Hruska BJ, Petrush K, Berman S, Sigmon SC, Fingerhood M, Bigelow GE. Opioid Overdose Experience, Risk Behaviors, and Knowledge in Drug Users from a Rural versus an Urban Setting. Journal of Substance Abuse Treatment. 71: 1-7. PMID 27672239 DOI: 10.1016/j.jsat.2016.08.006  0.84
2016 Dunn KE, Barrett FS, Herrmann ES, Plebani JG, Sigmon SC, Johnson MW. Behavioral risk assessment for infectious diseases (BRAID): Self-report instrument to assess injection and noninjection risk behaviors in substance users. Drug and Alcohol Dependence. 168: 69-75. PMID 27615403 DOI: 10.1016/j.drugalcdep.2016.07.032  0.84
2016 Sigmon SC, Bigelow GE. Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential. Addiction (Abingdon, England). PMID 27561982 DOI: 10.1111/add.13539  0.6
2016 Dunn KE, Barrett FS, Yepez-Laubach C, Meyer AC, Hruska BJ, Sigmon SC, Fingerhood M, Bigelow GE. Brief Opioid Overdose Knowledge (BOOK): A Questionnaire to Assess Overdose Knowledge in Individuals Who Use Illicit or Prescribed Opioids. Journal of Addiction Medicine. PMID 27504923 DOI: 10.1097/ADM.0000000000000235  0.84
2016 Stoops WW, Sigmon SC, Evans SM. Introduction to the special issue: 50th anniversary of APA Division 28: The past, present, and future of psychopharmacology and substance abuse. Experimental and Clinical Psychopharmacology. 24: 207-8. PMID 27454671 DOI: 10.1037/pha0000087  0.96
2016 Herrmann ES, Matusiewicz AK, Stitzer ML, Higgins ST, Sigmon SC, Heil SH. Contingency Management Interventions for HIV, Tuberculosis, and Hepatitis Control Among Individuals With Substance Use Disorders: A Systematized Review. Journal of Substance Abuse Treatment. PMID 27394070 DOI: 10.1016/j.jsat.2016.06.009  0.96
2016 Heil SH, Hand DJ, Sigmon SC, Badger GJ, Meyer MC, Higgins ST. Using Behavioral Economic Theory to Increase Use of Effective Contraceptives among Opioid-maintained Women at Risk of Unintended Pregnancy. Preventive Medicine. PMID 27346756 DOI: 10.1016/j.ypmed.2016.06.023  0.96
2015 Sigmon SC, Miller ME, Meyer AC, Saulsgiver K, Badger GJ, Heil SH, Higgins ST. Financial incentives to promote extended smoking abstinence in opioid-maintained patients: a randomized trial. Addiction (Abingdon, England). PMID 26638126 DOI: 10.1111/add.13264  0.96
2015 Sigmon SC, C Meyer A, Hruska B, Ochalek T, Rose G, Badger GJ, Brooklyn JR, Heil SH, Higgins ST, Moore BA, Schwartz RP. Bridging waitlist delays with interim buprenorphine treatment: Initial feasibility. Addictive Behaviors. 51: 136-42. PMID 26256469 DOI: 10.1016/j.addbeh.2015.07.030  0.96
2015 Miller ME, Sigmon SC. Are Pharmacotherapies Ineffective in Opioid-Dependent Smokers? Reflections on the Scientific Literature and Future Directions. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 17: 955-9. PMID 26180219 DOI: 10.1093/ntr/ntv030  0.48
2015 Miller ME, Badger GJ, Heil SH, Higgins ST, Sigmon SC. Associations between sensation seeking and d-amphetamine reinforcement. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. PMID 25846715 DOI: 10.1111/ajad.12226  0.96
2015 Dunn KE, Saulsgiver KA, Miller ME, Nuzzo PA, Sigmon SC. Characterizing opioid withdrawal during double-blind buprenorphine detoxification. Drug and Alcohol Dependence. 151: 47-55. PMID 25823907 DOI: 10.1016/j.drugalcdep.2015.02.033  0.96
2015 Meyer AC, Miller ME, Sigmon SC. Lifetime history of heroin use is associated with greater drug severity among prescription opioid abusers. Addictive Behaviors. 42: 189-93. PMID 25481453 DOI: 10.1016/j.addbeh.2014.11.006  0.96
2015 Miller ME, Sigmon SC. Are pharmacotherapies ineffective in opioid-dependent smokers? Reflections on the scientific literature and future directions Nicotine and Tobacco Research. 17: 955-959. DOI: 10.1093/ntr/ntv030  0.32
2015 Sigmon SC. Interim treatment: Bridging delays to opioid treatment access Preventive Medicine. DOI: 10.1016/j.ypmed.2015.04.017  0.96
2015 Fenn JM, Laurent JS, Sigmon SC. Increases in body mass index following initiation of methadone treatment Journal of Substance Abuse Treatment. 51: 59-63. DOI: 10.1016/j.jsat.2014.10.007  0.96
2015 Sigmon SC, Meyer AC, Hruska B, Ochalek T, Rose G, Badger GJ, Brooklyn JR, Heil SH, Higgins ST, Moore BA, Schwartz RP. Bridging waitlist delays with interim buprenorphine treatment: Initial feasibility Addictive Behaviors. 51: 136-142. DOI: 10.1016/j.addbeh.2015.07.030  0.96
2015 Sigmon SC. The untapped potential of office-based buprenorphine treatment Jama Psychiatry. 72: 395-396. DOI: 10.1001/jamapsychiatry.2014.2421  0.96
2014 Sigmon SC, Kennedy AG. The prescription opioid abuse epidemic in rural America: a look at how it begins Journal of Opioid Management. 10: 225-226. PMID 25162602 DOI: 10.5055/jom.2014.0210  0.96
2014 Patrick ME, Dunn KE, Badger GJ, Heil SH, Higgins ST, Sigmon SC. Spontaneous reductions in smoking during double-blind buprenorphine detoxification. Addictive Behaviors. 39: 1353-6. PMID 24845165 DOI: 10.1016/j.addbeh.2014.04.023  0.96
2014 Hand DJ, Heil SH, Sigmon SC, Higgins ST. Improving medicaid health incentives programs: lessons from substance abuse treatment research. Preventive Medicine. 63: 87-9. PMID 24613792 DOI: 10.1016/j.ypmed.2014.03.001  0.96
2014 Sigmon SC. Access to treatment for opioid dependence in rural america: Challenges and future directions Jama Psychiatry. 71: 359-360. PMID 24500040 DOI: 10.1001/jamapsychiatry.2013.4450  0.96
2013 Sigmon SC, Dunn KE, Saulsgiver K, Patrick ME, Badger GJ, Heil SH, Brooklyn JR, Higgins ST. A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers. Jama Psychiatry. 70: 1347-54. PMID 24153411 DOI: 10.1001/jamapsychiatry.2013.2216  0.96
2013 Dunn KE, Saulsgiver KA, Patrick ME, Heil SH, Higgins ST, Sigmon SC. Characterizing and improving HIV and hepatitis knowledge among primary prescription opioid abusers. Drug and Alcohol Dependence. 133: 625-32. PMID 24051063 DOI: 10.1016/j.drugalcdep.2013.08.007  0.96
2013 Rosenthal RN, Ling W, Casadonte P, Vocci F, Bailey GL, Kampman K, Patkar A, Chavoustie S, Blasey C, Sigmon S, Beebe KL. Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone. Addiction (Abingdon, England). 108: 2141-9. PMID 23919595 DOI: 10.1111/add.12315  0.96
2013 Herrmann ES, Heil SH, Sigmon SC, Dunn KE, Washio Y, Higgins ST. Characterizing and improving HIV/AIDS knowledge among cocaine-dependent outpatients using modified materials. Drug and Alcohol Dependence. 127: 220-5. PMID 22889696 DOI: 10.1016/j.drugalcdep.2012.07.006  0.96
2012 Heil SH, Gaalema DE, Johnston AM, Sigmon SC, Badger GJ, Higgins ST. Infant pupillary response to methadone administration during treatment for neonatal abstinence syndrome: a feasibility study. Drug and Alcohol Dependence. 126: 268-71. PMID 22682657 DOI: 10.1016/j.drugalcdep.2012.05.006  0.96
2012 Higgins ST, Silverman K, Sigmon SC, Naito NA. Incentives and health: an introduction. Preventive Medicine. 55: S2-6. PMID 22554884 DOI: 10.1016/j.ypmed.2012.04.008  0.96
2012 Sigmon SC, Patrick ME. The use of financial incentives in promoting smoking cessation Preventive Medicine. 55: S24-S32. PMID 22525802 DOI: 10.1016/j.ypmed.2012.04.007  0.96
2012 Sigmon SC, Bisaga A, Nunes EV, O'Connor PG, Kosten T, Woody G. Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice. The American Journal of Drug and Alcohol Abuse. 38: 187-99. PMID 22404717 DOI: 10.3109/00952990.2011.653426  0.96
2011 Dunn KE, Sigmon SC, Strain EC, Heil SH, Higgins ST. The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review. Drug and Alcohol Dependence. 119: 1-9. PMID 21741781 DOI: 10.1016/j.drugalcdep.2011.05.033  0.96
2011 Sigmon SC, Griffiths RR. Caffeine choice prospectively predicts positive subjective effects of caffeine and d-amphetamine. Drug and Alcohol Dependence. 118: 341-8. PMID 21600707 DOI: 10.1016/j.drugalcdep.2011.04.018  0.96
2011 Dunn KE, Saulsgiver KA, Sigmon SC. Contingency Management for Behavior Change: Applications to Promote Brief Smoking Cessation Among Opioid-Maintained Patients Experimental and Clinical Psychopharmacology. 19: 20-30. PMID 21341920 DOI: 10.1037/a0022039  0.96
2010 Dunn KE, Sigmon SC, Reimann EF, Badger GJ, Heil SH, Higgins ST. A contingency-management intervention to promote initial smoking cessation among opioid-maintained patients. Experimental and Clinical Psychopharmacology. 18: 37-50. PMID 20158293 DOI: 10.1037/a0018649  0.96
2009 Dunn KE, Sigmon SC, Reimann E, Heil SH, Higgins ST. Effects of Smoking Cessation on Illicit Drug Use among Opioid Maintenance Patients: A Pilot Study. Journal of Drug Issues. 39: 313-328. PMID 20401340  0.96
2009 Sigmon SC, Herning RI, Better W, Cadet JL, Griffiths RR. Caffeine withdrawal, acute effects, tolerance, and absence of net beneficial effects of chronic administration: cerebral blood flow velocity, quantitative EEG, and subjective effects. Psychopharmacology. 204: 573-85. PMID 19241060 DOI: 10.1007/s00213-009-1489-4  0.96
2009 Sigmon SC, Dunn KE, Badger GJ, Heil SH, Higgins ST. Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot study. Addictive Behaviors. 34: 304-11. PMID 19081679 DOI: 10.1016/j.addbeh.2008.11.017  0.96
2009 Dunn KE, Sigmon SC, Reimann E, Heil SH, Higgins ST. Effects of smoking cessation on illicit drug use among opioid maintenance patients: A pilot study Journal of Drug Issues. 39: 313-328.  0.96
2008 Dunn KE, Sigmon SC, Thomas CS, Heil SH, Higgins ST. Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot study. Journal of Applied Behavior Analysis. 41: 527-38. PMID 19192857 DOI: 10.1901/jaba.2008.41-527  0.96
2008 Heil SH, Sigmon SC, Jones HE, Wagner M. Comparison of characteristics of opioid-using pregnant women in rural and urban settings American Journal of Drug and Alcohol Abuse. 34: 463-471. PMID 18584576 DOI: 10.1080/00952990802122358  0.96
2008 Dunn KE, Sigmon SC, McGee MR, Heil SH, Higgins ST. Evaluation of ongoing oxycodone abuse among methadone-maintained patients. Journal of Substance Abuse Treatment. 35: 451-6. PMID 18295434 DOI: 10.1016/j.jsat.2007.12.006  0.96
2007 Sigmon SC. Investigating the pharmacological and nonpharmacological factors that modulate drug reinforcement Experimental and Clinical Psychopharmacology. 15: 1-20. PMID 17295581 DOI: 10.1037/1064-1297.15.1.1  0.96
2007 Higgins ST, Heil SH, Sigmon SC. A behavioral approach to the treatment of substance use disorders Functional Analysis in Clinical Treatment. 261-282. DOI: 10.1016/B978-012372544-8/50015-X  0.96
2006 Sigmon SC. Characterizing the emerging population of prescription opioid abusers American Journal On Addictions. 15: 208-212. PMID 16923666 DOI: 10.1080/10550490600625624  0.96
2006 Sigmon SC, Higgins ST. Voucher-based contingent reinforcement of marijuana abstinence among individuals with serious mental illness. Journal of Substance Abuse Treatment. 30: 291-5. PMID 16716843 DOI: 10.1016/j.jsat.2006.02.001  0.96
2006 Sigmon SC, Moody DE, Nuwayser ES, Bigelow GE. An injection depot formulation of buprenorphine: Extended biodelivery and effects Addiction. 101: 420-432. PMID 16499515 DOI: 10.1111/j.1360-0443.2006.01348.x  0.96
2006 Budney AJ, Moore BA, Sigmon SC, Higgins ST. Contingency-management interventions for cannabis dependence Cannabis Dependence: Its Nature, Consequences, and Treatment. 154-176. DOI: 10.1017/CBO9780511544248.009  0.96
2005 Sigmon SC, Stitzer ML. Use of a low-cost incentive intervention to improve counseling attendance among methadone-maintained patients. Journal of Substance Abuse Treatment. 29: 253-8. PMID 16311177 DOI: 10.1016/j.jsat.2005.08.004  0.96
2005 Correia CJ, Sigmon SC, Silverman K, Bigelow G, Stitzer ML. A comparison of voucher-delivery schedules for the initiation of cocaine abstinence. Experimental and Clinical Psychopharmacology. 13: 253-8. PMID 16173889 DOI: 10.1037/1064-1297.13.3.253  0.96
2005 Heil SH, Sigmon SC, Mongeon JA, Higgins ST. Characterizing and improving HIV/AIDS knowledge among cocaine-dependent outpatients. Experimental and Clinical Psychopharmacology. 13: 238-43. PMID 16173887 DOI: 10.1037/1064-1297.13.3.238  0.96
2005 Hughes CE, Sigmon SC, Pitts RC, Dykstra LA. Morphine tolerance as a function of ratio schedule: response requirement or unit price? Journal of the Experimental Analysis of Behavior. 83: 281-96. PMID 16050038 DOI: 10.1901/jeab.2005.35-04  0.96
2005 Rosado J, Sigmon SC, Jones HE, Stitzer ML. Cash value of voucher reinforcers in pregnant drug-dependent women. Experimental and Clinical Psychopharmacology. 13: 41-7. PMID 15727502 DOI: 10.1037/1064-1297.13.1.41  0.96
2005 Mueser KT, Drake RE, Sigmon SC, Brunette MF. Psychosocial interventions for adults with severe mental illnesses and co-occurring substance use disorders: A review of specific interventions Journal of Dual Diagnosis. 1: 57-82. DOI: 10.1300/J374v01n02_05  0.96
2004 Sigmon SC, Correia CJ, Stitzer ML. Cocaine abstinence during methadone maintenance: effects of repeated brief exposure to voucher-based reinforcement. Experimental and Clinical Psychopharmacology. 12: 269-75. PMID 15571444 DOI: 10.1037/1064-1297.12.4.269  0.96
2004 Sigmon SC, Wong CJ, Chausmer AL, Liebson IA, Bigelow GE. Evaluation of an injection depot formulation of buprenorphine: Placebo comparison Addiction. 99: 1439-1449. PMID 15500597 DOI: 10.1111/j.1360-0443.2004.00834.x  0.96
2004 Wong CJ, Anthony S, Sigmon SC, Mongeon JA, Badger GJ, Higgins ST. Examining interrelationships between abstinence and coping self-efficacy in cocaine-dependent outpatients. Experimental and Clinical Psychopharmacology. 12: 190-9. PMID 15301636 DOI: 10.1037/1064-1297.12.3.190  0.96
2004 Sobel BFX, Sigmon SC, Griffiths RR. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers Neuropsychopharmacology. 29: 991-1003. PMID 15010695 DOI: 10.1038/sj.npp.1300415  0.96
2004 Sobel BF, Sigmon SC, Walsh SL, Johnson RE, Liebson IA, Nuwayser ES, Kerrigan JH, Bigelow GE. Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification. Drug and Alcohol Dependence. 73: 11-22. PMID 14687955 DOI: 10.1016/j.drugalcdep.2003.08.006  0.96
2003 Higgins ST, Sigmon SC, Wong CJ, Heil SH, Badger GJ, Donham R, Dantona RL, Anthony S. Community reinforcement therapy for cocaine-dependent outpatients. Archives of General Psychiatry. 60: 1043-52. PMID 14557150 DOI: 10.1001/archpsyc.60.9.1043  0.96
2003 Sigmon SC, Tidey JW, Badger GJ, Higgins ST. Acute effects of D-amphetamine on progressive-ratio performance maintained by cigarette smoking and money. Psychopharmacology. 167: 393-402. PMID 12684732 DOI: 10.1007/s00213-003-1416-z  0.96
2002 Wong CJ, Badger GJ, Sigmon SC, Higgins ST. Examining possible gender differences among cocaine-dependent outpatients. Experimental and Clinical Psychopharmacology. 10: 316-23. PMID 12233993 DOI: 10.1037//1064-1297.10.3.316  0.96
2000 Sigmon SC, Steingard S, Badger GJ, Anthony SL, Higgins ST. Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study. Experimental and Clinical Psychopharmacology. 8: 509-17. PMID 11127422 DOI: 10.1037//1064-1297.8.4.509  0.96
Show low-probability matches.